Bloomberg Intelligence

Koons on Pfizer Agreeing to Buy Medivation (Audio)


Listen Later

(Bloomberg) -- Taking Stock with Kathleen Hays and Pimm Fox. \u0010 \u0010GUEST: \u0010Cynthia Koons \u0010Health Care Reporter \u0010Bloomberg Editorial \u0010on Pfizer beating out rivals to buy biopharmaceutical company, Medivation, and its blockbuster cancer drug for $14 billion.

See omnystudio.com/listener for privacy information.

...more
View all episodesView all episodes
Download on the App Store

Bloomberg IntelligenceBy Bloomberg